Skip to Main content Skip to Navigation
Journal articles

Soluble C-Met as a Biomarker of Clinical Outcomes After STEMI

S. Leboube 1 A. Paccalet 1 C. C. da Silva 1 A. Hayek 2, 3 F. Derimay 1 E. Bonnefoy-Cudraz 1 M. Ovize 1 N. Mewton 1 G. Bidaux 1 T. Bochaton 1 
1 CarMeN - Cardiovasculaire, métabolisme, diabétologie et nutrition
2 Hôpital Louis Pradel [CHU - HCL]
3 UCBL - Université Claude Bernard Lyon 1
Abstract : No abstract available
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-03344374
Contributor : laboratoire CarMeN Connect in order to contact the contributor
Submitted on : Wednesday, September 15, 2021 - 7:34:26 AM
Last modification on : Friday, September 17, 2021 - 3:24:53 AM
Long-term archiving on: : Thursday, December 16, 2021 - 6:07:53 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

INSERM | HCL | UNIV-LYON1 | CARMEN | UDL | INRAE

Citation

S. Leboube, A. Paccalet, C. C. da Silva, A. Hayek, F. Derimay, et al.. Soluble C-Met as a Biomarker of Clinical Outcomes After STEMI. Journal of the American College of Cardiology, Elsevier, 2021, 77 (18), pp.2348-2350. ⟨10.1016/j.jacc.2021.03.015⟩. ⟨inserm-03344374⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

6